Advertisement

PharmacoEconomics

, Volume 23, Issue 5, pp 449–459 | Cite as

Valuing patient and caregiver time

A review of the literature
  • Jennifer E. TranmerEmail author
  • Denise N. Guerriere
  • Wendy J. Ungar
  • Peter C. Coyte
Review Article

Abstract

As healthcare expenditures continue to rise, financial pressures have resulted in a desire for countries to shift resources away from traditional areas of spending. The consequent devolution and reform have resulted in increased care being provided and received within homes and communities, and in an increased reliance on unpaid caregivers. Recent empirical work indicates that costs incurred by care recipients and unpaid caregivers, including time and productivity costs, often account for significant proportions of total healthcare expenditures. However, many economic evaluations do not include these costs. Moreover, when indirect costs are assessed, the methods of valuation are inconsistent and frequently controversial.

This paper provides an overview and critique of existing valuation methods. Current methods such as the human capital method, friction cost method and the Washington Panel approach are presented and critiqued according to criteria such as potential for inaccuracy, ease of application, and ethical and distributional concerns. The review illustrates the depth to which the methods have been theoretically examined, and highlights a paucity of research on costs that accrue to unpaid caregivers and a lack of research on time lost from unpaid labour and leisure. To ensure accurate and concise reporting of all time costs, it is concluded that a broad conceptual approach for time costing should be developed that draws on and then expands upon theoretical work to date.

Keywords

Indirect Cost Leisure Time Labour Force Participation Rate Care Recipient Time Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This paper was presented, in part, at the Canadian Health Economics Research Association meetings in Halifax, Nova Scotia in May 2002. The authors would like to thank conference participants for their contributions, especially C. Donaldson, S. Hadad, A. Shiell and W. Tholl. In addition, comments from Bernie O’Brien were also much appreciated, as was funding from the Canadian Institutes for Health Research (Grant number 37883). The author has no real or potential conflicts of interest relevant to this manuscript.

References

  1. 1.
    Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1995Google Scholar
  2. 2.
    Andersson A, Levin L, Emtinger B. The economic burden of informal care. Int J Technol Assess Health Care 2002; 18 (1): 46–54PubMedGoogle Scholar
  3. 3.
    Coyte PC, Asche CV, Croxford R, et al. The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res 1998; 11 (5): 315–25PubMedCrossRefGoogle Scholar
  4. 4.
    Koopmanschap MA, Rutten FF. The impact of indirect costs on outcomes of health care programs. Health Econ 1994; 3 (6: 385–93PubMedCrossRefGoogle Scholar
  5. 5.
    Rothermich EA, Pathak DS. Productivity-cost controversies in cost-effectiveness analysis: review and research agenda. Clin Ther 1999; 21 (1): 255–67PubMedCrossRefGoogle Scholar
  6. 6.
    van den Berg B, Brouwer WBF, Koopmanschap MA. Economic valuation of informal care: an overview of methods and applications. Ear J Health Econ 2004; 5 (1): 36–45CrossRefGoogle Scholar
  7. 7.
    Olsen JA, Richardson J. Production gains from health care: what should be included in cost-effectiveness analyses? Soc Sci Med 1999; 49: 17–26PubMedCrossRefGoogle Scholar
  8. 8.
    Brouwer WBF, Koopmanschap MA, Rutten FFH. Patient and informal caregiver time in cost-effectiveness analysis: a response to the recommendations of the Washington Panel. Int J Technol Assess Health Care 1998; 14 (3): 505–13PubMedCrossRefGoogle Scholar
  9. 9.
    Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ 1997; 6 (5): 511–4CrossRefGoogle Scholar
  10. 10.
    Glied S. Estimating the indirect cost of illness: an assessment of the foregone earnings approach. Am J Public Health 1996; 86 (12): 1723–8PubMedCrossRefGoogle Scholar
  11. 11.
    Goeree R, O’Brien BJ, Blackhouse G, et al. The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia. Can J Psychiatry 1999; 44 (5): 455–63PubMedGoogle Scholar
  12. 12.
    Hutubessy RC, Van Tulder MW, Vondeling H et al. Indirect costs of back pain in The Netherlands: a comparison of human capital method with the friction cost method. Pain 1999; 80 (12): 201–7PubMedCrossRefGoogle Scholar
  13. 13.
    Jacobs P, Fassbender K. The measurement of indirect costs in the health economics evaluation literature: a review. Int J Technol Assess Health Care 1998; 14 (4): 799–808CrossRefGoogle Scholar
  14. 14.
    Koopmanschap MA, Rutten FF. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993; 4 (6): 446–54CrossRefGoogle Scholar
  15. 15.
    Koopmanschap MA, Rutten FFH. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 1996; 10: 460–6PubMedCrossRefGoogle Scholar
  16. 16.
    Koopmanschap MA, van Ineveld BM. Towards a new approach for estimation indirect costs of disease. Soc Sci Med 1992; 34: 1005–10PubMedCrossRefGoogle Scholar
  17. 17.
    Liljas D. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998; 13: 1–7PubMedCrossRefGoogle Scholar
  18. 18.
    Lofland III, Locklear JC, Frick KD. Different approaches to valuing the lost productivity of patients with migraine. Pharmacoeconomics 2001; 19 (9): 917–25PubMedCrossRefGoogle Scholar
  19. 19.
    Manning WG. Panel on cost-effectiveness in health and medicine recommendations: identifying costs. J Clin Psychiatry 1999; 60 Suppl. 3: 54–8PubMedGoogle Scholar
  20. 20.
    Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1253–8PubMedCrossRefGoogle Scholar
  21. 21.
    Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 1982; 60: 429–62PubMedCrossRefGoogle Scholar
  22. 22.
    Marcotte DE, Wilcox-Gok V. Estimating the employment and earnings costs of mental illness: recent developments in the United States. Soc Sci Med 2001; 53 (1): 21–7PubMedCrossRefGoogle Scholar
  23. 23.
    Mincer J, Polachek S. Family Investments in human capital: earnings of women. In: Schultz T, editor. Economics of the family: marriage, children, and human capital. Chicago (IL): National Bureau of Economic Research, The University of Chicago Press, 1974Google Scholar
  24. 24.
    Becker GS. Human capital. Vol. 2. New York (NY): National Bureau of Economic Research, 1975Google Scholar
  25. 25.
    Becker GS. A theory on the allocation of time. Econ J 1965; 75 (299): 493–517CrossRefGoogle Scholar
  26. 26.
    Borghouts JA, Koes BW, Vondeling H, et al. Cost-of-illness of neck pain in The Netherlands in 1996. Pain 1999; 80 (3): 629–36PubMedCrossRefGoogle Scholar
  27. 27.
    de Lissovoy G, Lazarus SS. The economic cost of migraine: present state of knowledge. Neurology 1994; 44 (6 Suppl. 4): S56–62PubMedGoogle Scholar
  28. 28.
    Evers SM, Engel GL, Ament AJ. Cost of stroke in The Netherlands from a societal perspective. Stroke 1997; 28 (7): 1375–81PubMedCrossRefGoogle Scholar
  29. 29.
    Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ 1995; 14: 171–89PubMedCrossRefGoogle Scholar
  30. 30.
    Stone PW, Chapman RH, Sandberg EA, et al. Measuring costs in cost-utility analyses: variations in the literature. Int J Technol Assess Health Care 2000; 16 (1): 111–24CrossRefGoogle Scholar
  31. 31.
    Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ 1997; 6 (3): 253–9PubMedCrossRefGoogle Scholar
  32. 32.
    Leigh JP, Romano PS, Schenker MB, et al. Costs of occupational COPD and asthma. Chest 2002; 121 (1): 264–72PubMedCrossRefGoogle Scholar
  33. 33.
    Ungar WJ, Coyle PC. Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board. Health Econ 2000; 9 (1): 37–46Google Scholar
  34. 34.
    Johannesson M, Karlsson G. The friction cost method: a comment. J Health Econ 1997; 16: 249–55PubMedCrossRefGoogle Scholar
  35. 35.
    Hutubessy RC, van Tulder MW, Vondeling H, et al. Indirect costs of back pain in The Netherlands: a comparison of the human capital method with the friction cost method. Pain 1999; 80 (1-2): 201–7PubMedCrossRefGoogle Scholar
  36. 36.
    Peeples PJ, Wertheimer AI, Mackowiak JI, et al. Controversies in measuring and valuing indirect costs of productivity foregone in a cost of illness evaluation. J Res Pharm Econ 1997; 8: 23–32Google Scholar
  37. 37.
    Posnett J, Jan S. Indirect cost in economic evaluation: the opportunity cost of unpaid input. Health Econ 1996; 5: 13–23PubMedCrossRefGoogle Scholar
  38. 38.
    Pritchard C, Sculpher M. Productivity costs: principles and practice in economic evaluation. London: The Office of Health Economics, 2000 NovGoogle Scholar
  39. 39.
    Weinstein MC, Seigel JE, Garber AM, et al. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ 1997; 6: 505–10PubMedCrossRefGoogle Scholar
  40. 40.
    Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. Reply to Johanesson’s and Karlsson’s comment [reply]. J Health Econ 1997; 16: 257–9CrossRefGoogle Scholar
  41. 41.
    Meltzer D, Johannesson M. Inconsistencies in the “societal perspective” on costs of the panel on cost-effectiveness in health and medicine. Med Decis Making 1999; 19 (4): 371–7PubMedCrossRefGoogle Scholar
  42. 42.
    Severens JL, Laheij RJ, Jansen JB, et al. Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther 1998 Sep; 12 (9): 919–23PubMedCrossRefGoogle Scholar
  43. 43.
    Brouwer WBF, van Excel NJ, Koopmanschap MA, et al. The valuation of informal care in economic appraisal. a consideration of individual choice and societal costs of time. Int J Technol Assess Health Care 1999; 15 (1): 147–60PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Jennifer E. Tranmer
    • 1
    Email author
  • Denise N. Guerriere
    • 1
  • Wendy J. Ungar
    • 1
    • 2
    • 3
  • Peter C. Coyte
    • 1
    • 3
    • 4
    • 5
  1. 1.Department of Health Policy, Management and EvaluationUniversity of TorontoTorontoCanada
  2. 2.Population Health SciencesThe Hospital for Sick Children Research InstituteTorontoCanada
  3. 3.Institute for Clinical Evaluative SciencesTorontoCanada
  4. 4.Canadian Health Services Research Foundation/Canadian Institutes of Health Research Health Service Chair, Department of Health Policy Management and EvaluationUniversity of TorontoTorontoCanada
  5. 5.Faculty of NursingUniversity of TorontoTorontoCanada

Personalised recommendations